Skip to content

Computational Neuroscience of Language Processing in the Human Brain

Computational Neuroscience of Language Processing in the Human Brain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05222594
Enrollment
40
Registered
2022-02-03
Start date
2021-04-02
Completion date
2027-03-31
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Language

Keywords

language, computational neuroscience, epilepsy

Brief summary

Language is a signature human cognitive skill, but the precise computations that support language understanding remain unknown. This study aims to combine high-quality human neural data obtained through intracranial recordings with advances in computational modeling of human cognition to shed light on the construction and understanding of speech.

Detailed description

The neural architecture of language is the foundation for the highest form of human interaction. Prior work has identified a network of frontal and temporal brain areas that selectively support language processing, but the precise computations that underlie our ability to extract meaning from sequences of words have remained unknown. The standard approaches in human cognitive neuroscience lack the spatial and temporal resolution necessary for precise comparisons to computational models. To bridge this gap in knowledge, neural responses to language stimuli will be collected from epileptic patients undergoing intracranial monitoring. Overall, these data will be used to identify cortical maps of different linguistic manipulations and to better understand properties of the human language network.

Interventions

OTHERBehavioral tasks during intracranial monitoring

Participants will listen to sentences and stories while neural data are recorded through electrodes placed for clinical purposes.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER
Massachusetts Institute of Technology
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* clinical indications to proceed with intracranial monitoring involving the left cerebral hemisphere, as determined by a multidisciplinary epilepsy surgery team * the ability to comply with test directions and provide informed consent * between ages 18 - 85

Exclusion criteria

* inability to understand or perform the task outlined in the protocol, or who are unwilling or unable to participate

Design outcomes

Primary

MeasureTime frameDescription
Cortical maps of linguistic responsesThroughout intracranial monitoring period, up to approximately 10 daysBy using sEEG intracranial recordings of the brain, EEG power in frequency bands will reflect cortical maps of responses to different linguistic manipulations, informing the functional organization of the human language system. Power is measured in arbitrary units; higher power reflects greater activity at the investigated frequency.
Neural time-courses during naturalistic language comprehensionThroughout intracranial monitoring period, up to approximately 10 daysTime-courses of neural response to language across diverse parts of the language network. These data will be used to predict across-time variation in response strength from the properties of linguistic input.
Brain scores for diverse artificial neural network (ANN) language modelsThroughout intracranial monitoring period, up to approximately 10 daysHuman neural data will be compared to ANN language models to test how well these models predict human responses to language and why. There are no minimum or maximum scores. Higher values mean better model predictivity (i.e., a better match between model representations and neural responses).

Countries

United States

Contacts

CONTACTEvelina Fedorenko, PhD
evelina9@mit.edu617-258-0670

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026